In 2015, there were 257,524 women with cervical cancer (CC) in the United States (U.S.). CC is preventable; screening detects early-stage cancer when treatment is most successful. This study aimed to identify predictors for CC screening adherence among U.S. women, describe predictors for screening adherence by marital status, and examine physician recommendation for CC screening and adherence to those recommendations. Predictors were grouped as demographic, acculturation, access to care, chronic conditions, and health behaviors. Descriptive analyses were performed on a sample of 10,667 women from the 2015 National Health Interview Survey, and multiple logistic regression models determined predictors of CC screening adherence, physician reco...
Background: Clinical practice screening guidelines recommend cotesting, a test that combines DNA Hum...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Cervical cancer screening is critical to early detection and treatment of precancerous cells and cer...
In 2015, there were 257,524 women with cervical cancer (CC) in the United States (U.S.). CC is preve...
Minority women groups in the United States have the highest incidence and mortality rates of cervica...
Following the latest update of cervical cancer screening guidelines in 2012, we estimate the prevale...
Hispanic women in Texas show higher cervical cancer incidence rates as compared to all women in the ...
Objective To assess women’s attitudes and preferences related to recent changes in cervical cancer ...
Background: A woman's risk for cervical cancer has been used by physicians to guide the initiation a...
Background: The most common cancers among women are breast and cervical cancer. Although early detec...
Cervical cancer is the second most common malignancy that affects women worldwide (WHO, 2011). Adher...
Objectives: Cervical cancer is the second-most common type of cancer among women aged 15-44, and rac...
The Papanicolaou (Pap) test is an effective screening mechanism for reducing morbidity and mortality...
Background: Cervical cancer is among the most common malignancies in women, especially in developing...
Thesis advisor: James LubbenIn 2011, an estimated 12,710 women suffered from cervical cancer and 4,2...
Background: Clinical practice screening guidelines recommend cotesting, a test that combines DNA Hum...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Cervical cancer screening is critical to early detection and treatment of precancerous cells and cer...
In 2015, there were 257,524 women with cervical cancer (CC) in the United States (U.S.). CC is preve...
Minority women groups in the United States have the highest incidence and mortality rates of cervica...
Following the latest update of cervical cancer screening guidelines in 2012, we estimate the prevale...
Hispanic women in Texas show higher cervical cancer incidence rates as compared to all women in the ...
Objective To assess women’s attitudes and preferences related to recent changes in cervical cancer ...
Background: A woman's risk for cervical cancer has been used by physicians to guide the initiation a...
Background: The most common cancers among women are breast and cervical cancer. Although early detec...
Cervical cancer is the second most common malignancy that affects women worldwide (WHO, 2011). Adher...
Objectives: Cervical cancer is the second-most common type of cancer among women aged 15-44, and rac...
The Papanicolaou (Pap) test is an effective screening mechanism for reducing morbidity and mortality...
Background: Cervical cancer is among the most common malignancies in women, especially in developing...
Thesis advisor: James LubbenIn 2011, an estimated 12,710 women suffered from cervical cancer and 4,2...
Background: Clinical practice screening guidelines recommend cotesting, a test that combines DNA Hum...
Among the identified barriers to HPV vaccination is the concern that women may compensate for their ...
Cervical cancer screening is critical to early detection and treatment of precancerous cells and cer...